Pharmaceutical

Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal

Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the production of investigational 225Ac-based radioligand therapy.

Aug 13, 2024 - 04:00
Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal
Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the production of investigational 225Ac-based radioligand therapy.
Read the original article

Tags:

Previous Article

FDA approves IASO Bio’s IND for equecabtagene autoleucel

Next Article

Era of ADCs: Pharma companies innovate to stand out in a buzzing market

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Morning Rounds: Why health care costs are nearly a fifth of the GDP

Morning Rounds: Why health care costs are nearly a fift...

Dec 21, 2023

Medicare Advantage update pushes Wall Street to reset expectations

Medicare Advantage update pushes Wall Street to reset e...

Jan 22, 2024

South Korean company Dong-A ST wins FDA approval for Stelara biosimilar

South Korean company Dong-A ST wins FDA approval for St...

Oct 12, 2024